The latest clinical and basic research findings on thyroid disease will be presented at the American Thyroid Association's (ATA) 78th Annual Meeting, October 4-7, 2007, at the Sheraton New York Hotel and Towers in New York City.
Individuals with subclinical hypothyroidism"”a mildly underactive thyroid only detectable by a blood test"”are twice as likely to develop heart failure, compared to those with normal thyroid levels.
Children of women with hypothyroidism"”an under-active thyroid"”who had elevated thyroid stimulating hormone (TSH) in the first and second trimesters of pregnancy, had a significantly reduced ability to see visual contrasts, compared to women with hypothyroidism with normal TSH levels during the first two trimesters, and pregnant women with normal thyroid levels
Despite great concerns that small amounts of ingested perchlorate"”a chemical which is ever-present in the environment"”decreases thyroid function among individuals, it has no effect on the thyroid function of women in early pregnancy, including those with a low-iodine diet.
Patients with micropapillary thyroid cancer"”small tumors equal to or less than 1 centimer"”and tumors even smaller, less than 1 millimeter (mm)"”are more common and not without a risk as previously thought.
The ATA will be offering a translational symposium on the topic of iodine deficiency disorders (IDD), which will be presented at its upcoming 78th Annual Meeting in New York. The special symposium will address the current needs and challenges associated with this important health issue and will be held at the Sheraton New York Hotel and Towers on Sunday, October 7 from 10:30 a.m. to Noon.
"Cardiovascular and Metabolic Issues in Patients with Thyroid Dysfunction: Implications for treating Hypo- or Hyperthyroidism" will be the focus of a day-long scientific meeting on Friday, March 28 at the Marriott Metro Center in Washington, DC.
Thyroid cancer experts will discuss updated guidelines for patients with thyroid nodules and differentiated thyroid cancer at a regional workshop. "Frontiers in Thyroid Cancer: ATA Guidelines in Clinical Practice" will take place on July 11-12, 2008 at the Boston Park Plaza Hotel in Boston.
The American Thyroid Association (ATA) and ThyCa: Thyroid Cancer Survivors' Association, Inc. are awarding two new research grants in 2008 and renewing two grants on thyroid cancer, one of the few cancers significantly increasing in the number of newly-diagnosed patients.
Thyroid cancer experts will discuss updated guidelines for patients with thyroid nodules and differentiated thyroid cancer at a regional workshop. "Frontiers in Thyroid Cancer: ATA Guidelines in Clinical Practice" will take place on July 11-12, 2008 at the Boston Park Plaza Hotel in Boston.
Scientific meeting of experts in thyroid health from around the world and presentation of latest clinical and basic research findings on thyroid disease.
Cancer recurrence is more common in patients with multifocal micropapillary cancer who are treated with less than near total thyroidectomy compared to patients with unifocal papillary cancer who are treated with less than near total thyroidectomy.
MicroRNA (miRNA) expression profiles can be used to identify an aggressive type of papillary thyroid cancer that is often otherwise difficult to detect.
Preterm infants with low thyroid hormone are significantly more likely to experience neurocognitive deficits at 3 months of age.
Patients 80 years old and over are significantly more likely to have complications following thyroid surgery than younger patients.
Genetic testing of thyroid nodules offers a new tool to diagnose thyroid cancer.
There is no correlation between newborn thyroid function within the normal range and cognitive development, nor is there a correlative between maternal thyroid function and newborn thyroid function in a Boston-area sample.
People with subclinical hyperthyroidism and subclinical hypothyroidism are at increased risk of all-cause death compared with people who have normally functioning thyroid.
People with moderate subclinical hypothyroidism (SCH), a condition in which the thyroid is mildly underactive, are at increased risk of death.
The American Thyroid Association (ATA) is proud to honor Paul W. Ladenson, M.D., of Johns Hopkins University School of Medicine in Baltimore, Md., with the 2008 Distinguished Service Award. This award, which recognizes important and continuing contributions to the organization, was presented today at the ATA's 79th Annual Meeting in Chicago, Ill.
The American Thyroid Association (ATA) is proud to honor Furio Pacini, M.D., of the University of Siena in Siena, Italy, with the 2008 Paul Starr Award for his outstanding contributions to clinical thyroidology. Dr. Pacini presented his lecture, "New Insights in Familial Non-Medullary Thyroid Cancer," today at the ATA's 79th Annual Meeting in Chicago, Ill., where he also received this prestigious award. The Paul Starr Award is supported by ATA Member Boris Catz, MD.
The American Thyroid Association (ATA) is proud to honor E. Chester Ridgway, MD, of the University of Colorado Denver in Denver, Colo., with the 2008 John B. Stanbury Thyroid Pathophysiology Medal. This award, which recognizes outstanding research contributions to the understanding of thyroid physiology or pathophysiology of thyroid disease, was presented today at the ATA's 79th Annual Meeting in Chicago, Ill.
The American Thyroid Association (ATA) is proud to honor James A. Fagin, M.D., of Memorial Sloan-Kettering Cancer Center in New York, N.Y., with the 2008 Sidney H. Ingbar Distinguished Lectureship Award. Dr. Fagin presented his lecture, "Insights into Thyroid Cancer Pathogenesis: Clinical and Therapeutic Relevance," today at the ATA's 79th Annual Meeting in Chicago, Ill., where he also received the award.
Carol Greenlee, MD of Grand Junction Co., has been elected as a director on the board of the American Thyroid Association (ATA). She will serve a four-year term of office (2008"“2012).
Terry F. Davies, M.D., an internationally recognized expert in thyroid disease, has been elected to become President of the American Thyroid Association (ATA) for a one-year term beginning in October 2009. He took office today as President-Elect at the ATA's 79th Annual Meeting in Chicago, Ill.
James A. Fagin, MD of New York, NY, has been elected as a director on the board of the American Thyroid Association (ATA). He will serve a four-year term of office (2008"“2012).
Chicago, Ill. "“ Kenneth D. Burman, MD, of Kensington, Md., was installed as President of the American Thyroid Association during the 79th Annual Meeting of the ATA being held at the Sheraton Chicago Hotel and Towers. The Annual Meeting drew a record attendance of over 1000 endocrinologists, surgeons, nuclear medicine physicians, research scientists, one-third of the attendees coming from 40 countries around the world.
The American Thyroid Association (ATA), the nation's leading organization in promoting thyroid health and understanding thyroid biology, will award more than $400,000 in research grants to eleven investigators at the 79th Annual Meeting of the ATA in Chicago, Ill. The ATA will also renew four 2007 research grants based on the current status of their research projects. These grants will support innovative research projects focused on the diagnosis and treatment of thyroid disease.
The American Thyroid Association's National Thyroid Cancer Workshop II. Frontiers in Thyroid Cancer: ATA Guidelines in Clinical Practice. Clinicians will discuss and debate treatment guidelines for thyroid cancer and offer research results.
The American Thyroid Association's National Thyroid Cancer Workshop II, "Frontiers in Thyroid Cancer: ATA Guidelines in Clinical Practice." Clinicians will discuss and debate treatment guidelines for thyroid cancer and offer research results.
The American Thyroid Association's National Thyroid Cancer Workshop II "Frontiers in Thyroid Cancer: ATA Guidelines in Clinical Practice." Clinicians will discuss and debate treatment guidelines for thyroid cancer and offer research results.
The American Thyroid Association's National Thyroid Cancer Workshop II "Frontiers in Thyroid Cancer: ATA Guidelines in Clinical Practice." Thyroid cancer experts will discuss and debate thyroid cancer treatment guidelines and offer research results.
The American Thyroid Association's National Thyroid Cancer Workshop II "Frontiers in Thyroid Cancer: ATA Guidelines in Clinical Practice." Thyroid cancer experts will discuss and debate thyroid cancer guidelines and offer research results.
The American Thyroid Association's National Thyroid Cancer Workshop II "Frontiers in Thyroid Cancer: ATA Guidelines in Clinical Practice." Thyroid cancer experts will discuss and debate treatment guidelines for thyroid cancer and offer research results.
The American Thyroid Association's National Thyroid Cancer Workshop II "Frontiers in Thyroid Cancer: ATA Guidelines in Clinical Practice." Thyroid cancer experts will discuss and debate treatment guidelines for thyroid cancer and offer research results.
The American Thyroid Association's National Thyroid Cancer Workshop II "Frontiers in Thyroid Cancer: ATA Guidelines in Clinical Practice." Thyroid cancer experts will discuss and debate treatment guidelines for thyroid cancer and offer research results.
The American Thyroid Association's National Thyroid Cancer Workshop II "Frontiers in Thyroid Cancer: ATA Guidelines in Clinical Practice." Thyroid cancer experts will discuss and debate treatment guidelines for thyroid cancer and offer research results.
The American Thyroid Association's National Thyroid Cancer Workshop II "Frontiers in Thyroid Cancer: ATA Guidelines in Clinical Practice." Thyroid cancer experts will discuss and debate treatment guidelines for thyroid cancer and offer research results.
Normal thyroid function in fetuses and breast-fed infants is dependent on sufficient intake of iodine and crucial for a child's normal neurocognitive development. Iodine deficiency during pregnancy can lead to serious adverse effects on child development. A study conducted by researchers at Boston University Medical Center has found that only 51 percent of U.S. prenatal multivitamins contain iodine.
Pregnancy has a great impact on the thyroid. During pregnancy, the thyroid gland produces 50 percent more thyroid hormone as compared to when a woman is not pregnant and may increase in size by 10-15 percent. Normal range for thyroid function tests differ during pregnancy as compared to when a woman is not pregnant.
The American Thyroid Association holds its "Research Summit and Spring Symposium on the Thyroid and Pregnancy" April 16 "“ 17 in Washington, D.C. Internationally prominent experts discuss issues such as changes in and stress placed upon the thyroid gland during pregnancy, the impact of hypothyroidism and hyperthyroidism, screening during pregnancy, and intervention and treatment.
The American Thyroid Association's "Research Summit and Spring Symposium on the Thyroid and Pregnancy" features internationally prominent experts on issues such as: the changes in and the stress placed upon the thyroid gland during pregnancy, the impact of hypothyroidism and hyperthyroidism, screening during pregnancy, clinical trials, intervention and treatment.
Children with Graves' disease in the U.S. who are routinely treated with the drug propylthiouracil are at-risk for suffering liver failure induced by this drug.
The American Thyroid Association, in cooperation with the European Thyroid Association, supports World Thyroid Day, May 25, 2009, marking it as a day to promote awareness and understanding of thyroid health and the advances made in treating thyroid diseases.
The American Thyroid Association has published the first set of comprehensive guidelines designed to standardize and optimize the diagnosis, treatment, and monitoring of patients with medullary thyroid carcinoma (MTC), an uncommon and challenging form of thyroid cancer.
The American Thyroid Association (ATA) will hold its 80th Annual Meeting. Attendees include nationally and internationally recognized thyroid clinicians and researchers presenting new research as well as treatment guidelines for thyroid diseases.
The American Thyroid Association, Inc. (ATA) is dedicated to education and research to improve thyroid disease prevention, diagnosis and treatment, improving thyroid patient care, and educating the public.
Iodine deficiency, which can result in thyroid conditions in adults and may cause mental handicap and contribute disproportionately to perinatal thyroid disease and death, is on the rise in Europe and Australia.
Anti-thyroid drugs are utilized to treat hyperthyroidism, which frequently occurs due to Graves’ disease. The mechanisms of action, clinical use and potential adverse effects of anti-thyroid drugs are examined.
Researchers present an update on clinical trials of thyroid hormone treatment during pregnancy.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right